SUPN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 47.94 USD 1.48% Market Closed

Market Cap: $2.8B

	Supernus Pharmaceuticals Inc NASDAQ:SUPN	US
V	Vinci SA XHAM:SQU	FR
E	Exotic Food PCL SET:XO	TH
N	NXP Semiconductors NV XMUN:VNX	NL
R	Regency Centers Corp F:RRC	US
	Ulisse Biomed Spa MIL:UBM	IT
M	Mitsubishi Kakoki Kaisha Ltd F:893	JP
E	Essential Utilities Inc SWB:A2A	US
	Bilfinger SE OTC:BFLBY	DE
	ActiveOps PLC F:95D	UK
	ARMOUR Residential REIT Inc NYSE:ARR	US
B	Becton Dickinson and Co DUS:BOX	US
A	Aflac Inc XMUN:AFL	US
H	HCA Healthcare Inc XMUN:2BH	US

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

85% > 90%

Negative Operating Margin

-8%

Low 3Y Average Operating Margin

Declining Operating Margin

3% > -8%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

7% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.